CN104664348A - 一种改善动脉粥样硬化的中药保健品 - Google Patents
一种改善动脉粥样硬化的中药保健品 Download PDFInfo
- Publication number
- CN104664348A CN104664348A CN201310629980.7A CN201310629980A CN104664348A CN 104664348 A CN104664348 A CN 104664348A CN 201310629980 A CN201310629980 A CN 201310629980A CN 104664348 A CN104664348 A CN 104664348A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- health product
- medicine health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 21
- 230000036541 health Effects 0.000 title claims abstract description 13
- 201000001320 Atherosclerosis Diseases 0.000 title abstract 2
- 241000222336 Ganoderma Species 0.000 claims abstract description 12
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 11
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 11
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 11
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 11
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 11
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 11
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 11
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 11
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 11
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 11
- 239000009636 Huang Qi Substances 0.000 claims abstract description 11
- 240000008365 Celosia argentea Species 0.000 claims abstract description 10
- 235000000722 Celosia argentea Nutrition 0.000 claims abstract description 10
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims abstract description 10
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 10
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims abstract description 9
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 4
- 230000003143 atherosclerotic effect Effects 0.000 claims description 11
- 241000112528 Ligusticum striatum Species 0.000 claims description 9
- 240000007164 Salvia officinalis Species 0.000 claims description 8
- 235000005412 red sage Nutrition 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 239000008187 granular material Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 2
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 230000002792 vascular Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 4
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 2
- 241000212322 Levisticum officinale Species 0.000 abstract 2
- 235000015468 Lycium chinense Nutrition 0.000 abstract 2
- 241000756042 Polygonatum Species 0.000 abstract 2
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 2
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract 2
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 2
- 239000001645 levisticum officinale Substances 0.000 abstract 2
- 244000132619 red sage Species 0.000 abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 241001092040 Crataegus Species 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000002107 myocardial effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 238000002399 angioplasty Methods 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 241001065361 Gynostemma Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000294142 Vascellum Species 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- -1 carrotene Substances 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 210000003017 ductus arteriosus Anatomy 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000013146 percutaneous coronary intervention Methods 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000250 revascularization Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000011122 softwood Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000020985 whole grains Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明涉及一种改善动脉粥样硬化的中药保健品，本发明中包括黄芪10～60份、丹参10～30份、川芎10～30份、山楂10～30份、青葙子10～30份、大枣10～60份、玉竹10～30份、枸杞10～40份、灵芝10～30份、绞股蓝10～30份。它是由下述重量份中药原料药合制而成：黄芪45份、丹参25份、川芎25份、山楂25份、青葙子20份、大枣45份、玉竹25份、枸杞30份、灵芝20份、绞股蓝20份。本发明利用传统中药和现代制剂技术，提高免疫力，补中益气，有效软化血管，疏通血管垃圾，改善血管弹性，能有效预防心脑血管疾病的发生。
Description
技术领域
本发明涉及一种改善动脉粥样硬化的中药保健品。
背景技术
动脉粥样硬化是一组称为动脉硬化的血管病中最常见、最重要的一种。其特点是动脉管壁增厚变硬、失去弹性和管腔缩小，由于在动脉内膜上积聚的脂质外观呈黄色粥样，因此称为动脉粥样硬化。主要累及大中型动脉，其临床表现主要以受累器官的病象为主。
现代医学治疗动脉粥样硬化主要包括对狭窄或闭塞的血管，特别是冠状动脉、肾动脉和四肢动脉施行再通或重建或旁路移植等外科手术，以恢复动脉的供血。用带球囊的导管进行经皮腔内血管成形术，将突入动脉管腔的粥样物质压向动脉壁而使血管畅通；在此基础上发展了经皮腔内血管旋切术、旋磨术、激光成形术等多种介入治疗，将粥样物质切下、磨碎、气化吸出而使血管再通。目前应用最多的还是经皮腔内血管成形术和支架包括药物洗脱支架植入术。
这种治疗方法对病患来说不仅痛苦较多，而且容易复发。因此，我们提供一种改善动脉粥样硬化的保健品，以配合医学治疗，更加有效的改善动脉粥样硬化，提高免疫力。
发明内容
本发明提供一种改善动脉粥样硬化的中药保健品，利用传统中药和现代制剂技术，提高免疫力，补中益气，有效软化血管，疏通血管垃圾，改善血管弹性，能有效预防心脑血管疾病的发生。
为此，本发明提供了如下中药：包括黄芪10～60份、丹参10～30份、川芎10～30份、山楂10～30份、青葙子10～30份、大枣10～60份、玉竹10～30份、枸杞10～40份、灵芝10～30份、绞股蓝10～30份。
上述中药由下述重量份中药原料药合制而成：黄芪45份、丹参25份、川芎25份、山楂25份、青葙子20份、大枣45份、玉竹25份、枸杞30份、灵芝20份、绞股蓝20份。
本发明所选药材及药理如下：
黄芪：黄芪有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。能消除实验性肾炎蛋白尿，增强心肌收缩力，调节血糖含量。不仅能扩张冠状动脉，改善心肌供血，提高免疫功能，而且能够延缓细胞衰老的进程。
丹参：归心、肝经。能祛瘀止痛、活血调经、降脂减肥、清心除烦。是治疗心、脑、血管疾病、肥胖及高脂血症的有效药物。
川芎：川芎煎剂对离体蟾蜍和蛙心脏，在浓度在1O-5-10-4时使收缩振幅增大、心率稍慢。
山楂：酸、甘，微温。归脾、胃、肝经。消食化积，活血散瘀。现代研究山楂含糖类、蛋白质、脂肪、维生素C、胡萝卜素、淀粉、苹果酸、枸橼酸、钙和铁等物质，具有降血脂、血压、强心和抗心律不齐等作用。
青葙子：性微寒，味苦。归肝经。用于肝热目赤、眼生翳膜、视物昏花、肝火眩晕。
大枣：所含有的环磷酸腺苷，是人体细胞能量代谢的必需成分，能够增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养，对防治心血管系统疾病有良好的作用。
玉竹：甘，平。滋阴润肺，生津养胃。玉竹能提高机体免疫功能，抑制癌瘤的生长，此外，本品还有强心、调节血压、增加冠脉流量、降血脂，抗动脉粥样硬化以及抗菌等作用。
枸杞：甘，平。养肝，滋肾，润肺。枸杞多糖具有促进免疫、抗衰老、抗肿瘤、清除自由基、抗疲劳、抗辐射、保肝、生殖功能保护和改善等作用。
灵芝：性平，味苦，无毒，主胸中结，益心气，补中，增智慧，不忘，久服轻身不老，延年神仙。在用灵芝治疗冠心病的过程中，发现在冠心病改善的同时，伴随的心律失常也随着好转和消失，于是采用灵芝注射液治疗各种心律失常，取得一定的效果。
绞股蓝：味苦；微甘；性凉。归肺；脾；肾经。益气健脾，化痰止咳，清热解毒。主治体虚乏力；虚劳失精；白细胞减少症；高脂血症；病毒性肝炎；慢性胃肠炎；慢性气管炎。
具体实施方式
实施例1：
将黄芪45份、丹参25份、川芎25份、山楂25份、青葙子20份、大枣45份、玉竹25份、枸杞30份、灵芝20份、绞股蓝20份，置于干净容器中，用蒸馏水浸泡1小时，备用。
运用回流法将浸泡后的黄芪、丹参、川芎、山楂、青葙子、大枣、玉竹、枸杞、灵芝、绞股蓝。在90℃的温度下进行提取，蒸馏水的用量为提取原料药材总重量的8倍，提取时间为2小时，提取次数2次；滤过，合并滤液，滤液浓缩至相对密度为1.70(70℃)的浸膏，收集浸膏，备用。
将适量VE、叶酸、牛黄酸、淀粉、糊精加入至浸膏中制软材，过18目筛制粒，60℃干燥1小时，过16目筛整粒。
将上述颗粒装入袋中并封口即为本保健品的颗粒剂。
实施例2：
将黄芪、丹参、川芎、山楂、青葙子、大枣、玉竹、枸杞、灵芝、绞股蓝，干燥粉碎后过120目筛，放入提取罐内，用水提醇沉法提取后干燥成粉，然后加10倍水溶解，除菌装瓶，即得口服液。
Claims (3)
1.一种改善动脉粥样硬化的中药保健品，其特征在于：本发明中包括黄芪10～60份、丹参10～30份、川芎10～30份、山楂10～30份、青葙子10～30份、大枣10～60份、玉竹10～30份、枸杞10～40份、灵芝10～30份、绞股蓝10～30份。
2.根据权利要求1所述的改善动脉粥样硬化的中药保健品，其特征在于：它是由下述重量份中药原料药合制而成：黄芪45份、丹参25份、川芎25份、山楂25份、青葙子20份、大枣45份、玉竹25份、枸杞30份、灵芝20份、绞股蓝20份。
3.根据权利要求1和权利要求2所述，其特征在于：这种改善动脉粥样硬化的保健品的剂型可以为颗粒剂，口服液或胶囊剂等。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310629980.7A CN104664348A (zh) | 2013-12-02 | 2013-12-02 | 一种改善动脉粥样硬化的中药保健品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310629980.7A CN104664348A (zh) | 2013-12-02 | 2013-12-02 | 一种改善动脉粥样硬化的中药保健品 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104664348A true CN104664348A (zh) | 2015-06-03 |
Family
ID=53300353
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310629980.7A Withdrawn CN104664348A (zh) | 2013-12-02 | 2013-12-02 | 一种改善动脉粥样硬化的中药保健品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104664348A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055856A (zh) * | 2015-08-14 | 2015-11-18 | 宋秋生 | 一种治疗心脑血管疾病的茶色素中药组合物及其制备方法和用途 |
-
2013
- 2013-12-02 CN CN201310629980.7A patent/CN104664348A/zh not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105055856A (zh) * | 2015-08-14 | 2015-11-18 | 宋秋生 | 一种治疗心脑血管疾病的茶色素中药组合物及其制备方法和用途 |
| CN105055856B (zh) * | 2015-08-14 | 2018-08-28 | 宋秋生 | 一种治疗心脑血管疾病的茶色素中药组合物及其制备方法和用途 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1170588A (zh) | 一种纯天然植物人体生命核能营养基质 | |
| CN107029146A (zh) | 一种清肺化痰补气健脾养肺的中药组合物及其制备方法 | |
| CN105166235A (zh) | 一种气血双补降三高的保健茶及其制备方法 | |
| CN103805418A (zh) | 一种海参酒 | |
| CN108210867A (zh) | 一种治疗疼痛的掌灸液及其制备方法 | |
| CN104758806A (zh) | 一种治疗冠心病的煎膏剂及其制备方法 | |
| CN103690784B (zh) | 治疗糖尿病肾病合并高血压肾病的中药组合物及制备方法 | |
| CN104783210A (zh) | 灵芝药膳鸭及其制作方法 | |
| CN107519310B (zh) | 提高精力抑制肿瘤细胞生长功能的中药组合物和制备工艺 | |
| CN108310298A (zh) | 一种具有缓解眼疲劳、防治近视的中药组合物及制备方法 | |
| CN104666888A (zh) | 一种提高免疫力的中药保健品 | |
| CN104664348A (zh) | 一种改善动脉粥样硬化的中药保健品 | |
| CN107308266A (zh) | 一种女性养生保健组合物及制备方法和应用 | |
| CN104250607A (zh) | 一种八味枸杞保健酒 | |
| CN103623246B (zh) | 一种治疗高血压及其并发症的中药制剂 | |
| CN105617268A (zh) | 一种治疗鳞屑角化型脚气的药物 | |
| CN112494614A (zh) | 一种木瓜百药组合防治癌病的中药配方 | |
| CN104082670A (zh) | 一种具有降血压功效的养生粥及其制作方法 | |
| CN104825864A (zh) | 对放疗具有增效作用的保健药膳及制备方法 | |
| CN104398626A (zh) | 风心病合并心悸怔忡补益心脾药剂及制备方法 | |
| CN108887658A (zh) | 一种治疗糖尿病的保健酱油及其制作方法 | |
| CN106110055A (zh) | 一种松苓草颗粒及其制备方法 | |
| CN104083734A (zh) | 治疗低血压的中药制剂 | |
| CN102895551B (zh) | 一种治疗慢性肾衰竭的中药 | |
| CN104082669A (zh) | 降低血液粘稠度的养生粥及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C04 | Withdrawal of patent application after publication (patent law 2001) | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20150603 |